Case Study - Balloon Kyphoplasty, L1 Compression Fracture (Osteoporosis)

L1 Compression Fracture, Osteoporosis

Patient Data:
Gender: F
Age: 92
Level Treated: L1
Condition of Bone: Primary Osteoporosis
Age of Fracture: 3.5 weeks

Case Information:
Specialist: Roger Thorne, M.D., Orthopaedic Surgeon
Products Used: KyphX Xpander® IBT 15/3
Date: May 2006

Case Highlights:
Dr. Thorne used KyphX Xpander® 15/3 balloons to achieve successful deformity correction on a severely collapsed vertebral body.

Case History:
This 92-year-old female patient presented with back pain. Plain-films and MRI revealed a vertebral compression fracture at L1. At 8 days the vertebra had further collapsed into vertebra plana. The patient had increased kyphosis as well as loss of overall standing height. Balloon kyphoplasty was done at 3.5 weeks.

pre-kyphoplasty, L1 compression fracture
Pre-kyphoplasty: Pathologic compression fracture (vertebra plana) at L1.

Procedure and Results:
Dr. Thorne used a transpedicular approach with KyphX Xpander® IBT 15/3 balloons. The IBTs were inflated superiorly to a volume of 3cc on each side. 6 cc of cement were used to fill the cavity created by the balloons. Local vertebral body angular deformity correction was achieved. Endplates were better aligned and a notable reduction in kyphosis was observed. The patient obtained significant pain relief. At one month follow-up the patient was ambulatory without assistance.

post-kyphoplasty, correction of L1 compression fracture
Post-kyphoplasty: Significant correction of vertebra plana.

Kyphon Inc.'s Fracture:Line, Volume 3, Number 2 - Fall 2006

As with any surgery, there are potential risks. Although balloon kyphoplasty is designed to minimize these risks as much as possible, there is a chance that complications could occur. Serious adverse events can occur including: myocardial infarction (heart attack), cerebrovascular accident (stroke), pulmonary embolism (cement leakage that migrates to the lungs), cardiac arrest (heart stops beating), paralysis or muscle weakness, death. Patients should consult with their doctor for a full discussion of risks.

Last Updated: 05/08/2007